Literature DB >> 14763741

Purification of recombinant DNA-derived factor IX produced in transgenic pig milk and fractionation of active and inactive subpopulations.

Myles Lindsay1, Geun-Cheol Gil, Armando Cadiz, William H Velander, Chenming Zhang, Kevin E Van Cott.   

Abstract

Transgenic animal bioreactors can be engineered to make gram per liter quantities of complex recombinant glycoproteins in milk. However, little is known about the limitations in post-translational processing that occurs for very complex proteins and how this impacts the task of purification. We report on the purification of recombinant factor IX (rFIX) from the milk of transgenic pigs having an expression level of 2-3 g rFIX/(l(-1) h(-1)), an expression level that is about 20-fold higher than previously reported. This purification process efficiently recovers highly active rFIX and shows that even complex mixtures like pig milk, which contains 60 g/l total endogenous milk protein and multiple subpopulations of rFIX, can be processed using conventional, non-immunoaffinity chromatographic methods. Without prior removal of caseins, heparin-affinity chromatography was used to first purify the total population of rFIX at greater than 90% yield. After the total population was isolated, the biologically active and inactive subpopulations were fractionated by high-resolution anion exchange chromatography using an ammonium acetate elution. Capillary isoelectric focusing of the active and inactive rFIX fractions demonstrated that the active subpopulations are the most acidic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14763741     DOI: 10.1016/j.chroma.2003.11.006

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  13 in total

1.  The effect of osmotic stress on the cell volume, metaphase II spindle and developmental potential of in vitro matured porcine oocytes.

Authors:  S F Mullen; M Rosenbaum; J K Critser
Journal:  Cryobiology       Date:  2007-04-04       Impact factor: 2.487

Review 2.  Genetic modifications of pigs for medicine and agriculture.

Authors:  Jeffrey J Whyte; Randall S Prather
Journal:  Mol Reprod Dev       Date:  2011-06-10       Impact factor: 2.609

3.  A galactopoiesis accordant yield of functional recombinant human factor IX from homozygous transgenic pigs requires a large amount of vitamin K supplementation.

Authors:  Chon-Ho Yen; Tien-Shuh Yang; Yin-Shen Lin; Meng-Hwan Lee; Kuo-Cheng Yu; Chung-Lin Huang; How-Hong Hsieh; Ching-Fu Tu
Journal:  Transgenic Res       Date:  2016-05-09       Impact factor: 2.788

4.  High throughput quantification of N-glycans using one-pot sialic acid modification and matrix assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  Geun-Cheol Gil; Bryce Iliff; Ron Cerny; William H Velander; Kevin E Van Cott
Journal:  Anal Chem       Date:  2010-08-01       Impact factor: 6.986

5.  Quantifying vitamin K-dependent holoprotein compaction caused by differential γ-carboxylation using high-pressure size exclusion chromatography.

Authors:  Nicholas C Vanderslice; Amanda S Messer; Kanagasabai Vadivel; S Paul Bajaj; Martin Phillips; Mostafa Fatemi; Weijie Xu; William H Velander
Journal:  Anal Biochem       Date:  2015-03-22       Impact factor: 3.365

6.  Calumenin knockdown, by intronic artificial microRNA, to improve expression efficiency of the recombinant human coagulation factor IX.

Authors:  Javad Parnian; Maryam Hoseindokht; Zahra Khademi; Maedeh Moosavi; Zahra Soheila Soheili; Shahram Samie; Alireza Zomorodipour
Journal:  Biotechnol Lett       Date:  2022-04-12       Impact factor: 2.461

7.  Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk.

Authors:  Geun-Cheol Gil; William H Velander; Kevin E Van Cott
Journal:  Glycobiology       Date:  2008-05-02       Impact factor: 4.313

8.  Could protein tertiary structure influence mammary transgene expression more than tissue specific codon usage?

Authors:  Zuyong He; Yiqiang Zhao; Gui Mei; Ning Li; Yaosheng Chen
Journal:  Transgenic Res       Date:  2010-06-19       Impact factor: 2.788

Review 9.  Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwide.

Authors:  K E Van Cott; P E Monahan; T C Nichols; W H Velander
Journal:  Haemophilia       Date:  2004-10       Impact factor: 4.287

Review 10.  Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system.

Authors:  Susan A Brooks
Journal:  Mol Biotechnol       Date:  2004-11       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.